Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INCCOLL · Entity 5169 | EVP & Chief Technical Officer | August 10, 2021 | August 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COLLEGIUM PHARMACEUTICAL, INC
Report date August 10, 2021 · Filed August 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 143,694 |
Reported balance
After 2021-08-10 transaction · row 1
1 source rowRow 1 · 2021-08-10 · Tax withholding · Disposed 1,386 · Balance 143,694 F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2021 Filed Aug 12, 2021 16:03 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 1,386 | $19.03 | $26,375.58 |
DisclosureSEC source: 0001192482-21-000662 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,694 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 18:54 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 7,900 | $23.38 | $184,702.00 |
DisclosureSEC source: 0001192482-21-000309 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,080 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 18:54 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 1,757 | $23.38 | $41,078.66 |
DisclosureSEC source: 0001192482-21-000309 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · EVP & Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,980 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 16:14 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 5,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000288 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,737 F1 · price: On March 30, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 5,984 performance share units granted on February 5, 2020. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:01 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 6,011 | $23.36 | $140,416.96 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 12 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,753 F4 · kind: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:15 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 5,045 | $25.95 | $130,917.75 |
DisclosureSEC source: 0001192482-21-000149 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,164 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:15 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 2,099 | $25.95 | $54,469.05 |
DisclosureSEC source: 0001192482-21-000149 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,209 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:30 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantStock Option (Right to Purchase) · Derivative | 129,600 | $0.00 Strike: $24.06 | $0.00 |
DisclosureSEC source: 0001192482-21-000086 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,600 Underlying: Common Stock · 129,600 shares Expires 2031-01-19 F3 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:30 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 6,529 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000086 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,308 F2 · price: On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,529 performance share units granted in two prior years. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:30 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 45,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000086 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,779 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 16:12 UTC Amendment | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 6,529 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000101 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,308 F2 · price: On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,529 performance share units granted in two prior years. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 16:12 UTC Amendment | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 45,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000101 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,779 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 16,042 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · derivative · entry 6 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,042 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was fully vested and exercisable as of January 7, 2021. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 16,042 | $22.00 | $352,924.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 4 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,419 F3 · kind: The sales occurring on January 7, 2021 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 16,042 | $5.73 | $91,920.66 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 16:03 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 5,967 | $19.24 | $114,805.08 |
DisclosureSEC source: 0001192482-20-000799 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,419 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.03 to $19.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 16:28 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 16,000 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-20-000793 · edgar.xml · derivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,378 Underlying: Common Stock · 16,000 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was fully vested and exercisable as of November 18, 2020. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 16:28 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 16,000 | $5.73 | $91,680.00 |
DisclosureSEC source: 0001192482-20-000793 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 16:04 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 1,515 | $18.89 | $28,618.35 |
DisclosureSEC source: 0001192482-20-000665 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,386 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| May 13, 2020 Filed May 15, 2020 16:16 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 2,728 | $22.74 | $62,034.72 |
DisclosureSEC source: 0001192482-20-000347 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,901 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.19 to $22.98, inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 16:16 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 5,261 | $21.12 | $111,112.32 |
DisclosureSEC source: 0001192482-20-000347 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,629 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.89 to $21.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 16:28 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 3,568 | $21.62 | $77,140.16 |
DisclosureSEC source: 0001192482-20-000151 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,890 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-02-05 F3 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 18,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,458 F2 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 1, 2021, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on the vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,842 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:27 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 214 | $21.56 | $4,613.84 |
DisclosureSEC source: 0001192482-20-000044 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,342 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,378 Underlying: Common Stock · 25,000 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was fully vested and exercisable as of November 8, 2019. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 25,000 | $19.44 | $486,000.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,556 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.71, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 25,000 | $5.73 | $143,250.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 16:47 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 1,517 | $11.24 | $17,051.08 |
DisclosureSEC source: 0001192482-19-000341 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,556 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| July 19, 2019 Filed Jul 23, 2019 16:04 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 181 | $10.35 | $1,873.35 |
DisclosureSEC source: 0001192482-19-000322 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,073 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 08, 2019 Filed Feb 11, 2019 17:03 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 2,714 | $14.39 | $39,054.46 |
DisclosureSEC source: 0001192482-19-000075 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,254 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 16:42 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantStock Option (Right to Purchase) · Derivative | 25,600 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001192482-19-000059 · edgar.xml · derivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,600 Underlying: Common Stock · 25,600 shares Expires 2029-01-25 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2019 Filed Jan 29, 2019 16:42 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 25,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000059 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,968 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:17 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 214 | $15.76 | $3,372.64 |
DisclosureSEC source: 0001192482-19-000041 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,368 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 16:04 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 599 | $18.03 | $10,799.97 |
DisclosureSEC source: 0001192482-18-000413 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,582 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 17:39 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 181 | $20.15 | $3,647.15 |
DisclosureSEC source: 0001192482-18-000376 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,181 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 16:58 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 4,096 | $27.00 | $110,592.00 |
DisclosureSEC source: 0001192482-18-000292 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,362 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| May 10, 2018 Filed Mar 3, 2021 20:01 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 1,400 | $27.00 | $37,800.00 |
DisclosureSEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 11 Fleming Alison B · CIK 0001640701 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,764 F3 · kind: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock option (right to purchase) · Derivative | 3,917 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 4 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,917 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 3,917 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vested and became exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vested in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock option (right to purchase) · Derivative | 4,225 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,225 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 4,225 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vested and became exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 3,917 | $0.28 | $1,096.76 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:50 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 4,225 | $0.28 | $1,183.00 |
DisclosureSEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 16:03 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 1,193 | $21.77 | $25,971.61 |
DisclosureSEC source: 0001192482-18-000097 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,316 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 16:16 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Tax withholdingCommon Stock | 214 | $23.38 | $5,003.32 |
DisclosureSEC source: 0001192482-18-000076 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,509 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 19:37 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantStock Option (Right to Purchase) · Derivative | 50,000 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001192482-18-000061 · edgar.xml · derivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-25 F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 19:37 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000061 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,723 F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 3,336 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · derivative · entry 5 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,042 Underlying: Common Stock · 3,336 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | SaleCommon Stock | 3,336 | $23.00 | $76,728.00 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,419 F2 · kind: The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| January 19, 2018 Filed Jan 11, 2021 17:06 UTC | COLLEGIUM PHARMACEUTICAL, INC COLL · Entity 5169 | Exercise / conversionCommon Stock | 3,336 | $5.73 | $19,115.28 |
DisclosureSEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.